TRIL
Trillium Therapeutics Inc.
TRIL
TRIL
Delisted
TRIL was delisted on the 16th of November, 2021.
34 hedge funds and large institutions have $69.9M invested in Trillium Therapeutics Inc. in 2015 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
34
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$9.18M | |
| 2 | +$8.62M | |
| 3 | +$8.18M | |
| 4 |
EAM
EverPoint Asset Management
Stamford,
Connecticut
|
+$6.55M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$4.11M |
Top Sellers
| 1 | -$1.45M | |
| 2 | -$1.17M | |
| 3 | -$506K | |
| 4 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$218K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$24K |